相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial
Joaquin Mateo et al.
LANCET ONCOLOGY (2020)
Role of Akt Activation in PARP Inhibitor Resistance in Cancer
Ferenc Gallyas et al.
CANCERS (2020)
PARP inhibitor resistance: the underlying mechanisms and clinical implications
He Li et al.
MOLECULAR CANCER (2020)
Phase I Trial of the PARP Inhibitor Olaparib and AKT Inhibitor Capivasertib in Patients with BRCA1/2- and Non-BRCA1/2-Mutant Cancers
Timothy A. Yap et al.
CANCER DISCOVERY (2020)
Emerging connectivity of programmed cell death pathways and its physiological implications
Sammy Bedoui et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
DNA damage induced by KP372-1 hyperactivates PARP1 and enhances lethality of pancreatic cancer cells with PARP inhibition
Talysa Viera et al.
SCIENTIFIC REPORTS (2020)
Poly(ADP-ribosyl)ation by PARP1: reaction mechanism and regulatory proteins
Elizaveta E. Alemasova et al.
NUCLEIC ACIDS RESEARCH (2019)
Moving From Poly (ADP-Ribose) Polymerase Inhibition to Targeting DNA Repair and DNA Damage Response in Cancer Therapy
Charlie Gourley et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
Talia Golan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
PARP Inhibitor Resistance: A Tug-of-War in BRCA-Mutated Cells
Sylvie M. Noordermeer et al.
TRENDS IN CELL BIOLOGY (2019)
PARP inhibition induces Akt-mediated cytoprotective effects through the formation of a mitochondria-targeted phospho-ATM-NEMO-Akt-mTOR signalosome
Antal Tapodi et al.
BIOCHEMICAL PHARMACOLOGY (2019)
ROS and the DNA damage response in cancer
Upadhyayula Sai Srinivas et al.
REDOX BIOLOGY (2019)
Getting the Akt Together: Guiding Intracellular Akt Activity by PI3K
Ivan Yudushkin
BIOMOLECULES (2019)
Latest clinical evidence and further development of PARP inhibitors in ovarian cancer
M. R. Mirza et al.
ANNALS OF ONCOLOGY (2018)
Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion
Mario Mauthe et al.
AUTOPHAGY (2018)
Selective eradication of cancer displaying hyperactive Akt by exploiting the metabolic consequences of Akt activation
Veronique Nogueira et al.
ELIFE (2018)
Critical role of FOXO3a in carcinogenesis
Ying Liu et al.
MOLECULAR CANCER (2018)
The multifaceted roles of PARP1 in DNA repair and chromatin remodelling
Arnab Ray Chaudhuri et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
Leveraging an NQO1 Bioactivatable Drug for Tumor-Selective Use of Poly(ADP-ribose) Polymerase Inhibitors
Xiumei Huang et al.
CANCER CELL (2016)
p62 links the autophagy pathway and the ubiqutin-proteasome system upon ubiquitinated protein degradation
Wei Jing Liu et al.
CELLULAR & MOLECULAR BIOLOGY LETTERS (2016)
NQO1-Mediated Tumor-Selective Lethality and Radiosensitization for Head and Neck Cancer
Long-Shan Li et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Landscape of Phosphatidylinositol-3-Kinase Pathway Alterations Across 19 784 Diverse Solid Tumors
Sherri Z. Millis et al.
JAMA ONCOLOGY (2016)
SoNar, a Highly Responsive NAD+/NADH Sensor, Allows High-Throughput Metabolic Screening of Anti-tumor Agents
Yuzheng Zhao et al.
CELL METABOLISM (2015)
Structures and Mechanisms of Enzymes Employed in the Synthesis and Degradation of PARP-Dependent Protein ADP-Ribosylation
Eva Barkauskaite et al.
MOLECULAR CELL (2015)
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
J. Mateo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Calcium and ROS: A mutual interplay
Agnes Goerlach et al.
REDOX BIOLOGY (2015)
Tumour cell retention of rucaparib, sustained PARP inhibition and efficacy of weekly as well as daily schedules
J. Murray et al.
BRITISH JOURNAL OF CANCER (2014)
Improving chemoradiation efficacy by PI3-K/AKT inhibition
Hanneke Stegeman et al.
CANCER TREATMENT REVIEWS (2014)
Role of AKT signaling in DNA repair and clinical response to cancer therapy
Qun Liu et al.
NEURO-ONCOLOGY (2014)
Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma
Brett E. Johnson et al.
SCIENCE (2014)
Vulnerabilities of PTEN-TP53-Deficient Prostate Cancers to Compound PARP-PI3K Inhibition
Enrique Gonzalez-Billalabeitia et al.
CANCER DISCOVERY (2014)
Catalase Abrogates β-Lapachone-Induced PARP1 Hyperactivation-Directed Programmed Necrosis in NQO1-Positive Breast Cancers
Erik A. Bey et al.
MOLECULAR CANCER THERAPEUTICS (2013)
DNA Base Damage by Reactive Oxygen Species, Oxidizing Agents, and UV Radiation
Jean Cadet et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
An NQO1 Substrate with Potent Antitumor Activity That Selectively Kills by PARP1-Induced Programmed Necrosis
Xiumei Huang et al.
CANCER RESEARCH (2012)
PARP-1 Modulation of mTOR Signaling in Response to a DNA Alkylating Agent
Chantal Ethier et al.
PLOS ONE (2012)
PI3K Inhibition Impairs BRCA1/2 Expression and Sensitizes BRCA-Proficient Triple-Negative Breast Cancer to PARP Inhibition
Yasir H. Ibrahim et al.
CANCER DISCOVERY (2012)
AKT/FOXO Signaling Enforces Reversible Differentiation Blockade in Myeloid Leukemias
Stephen M. Sykes et al.
CELL (2011)
Selective p38α Inhibitors Clinically Evaluated for the Treatment of Chronic Inflammatory Disorders
David M. Goldstein et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
H2AX Phosphorylation: Its Role in DNA Damage Response and Cancer Therapy
Monika Podhorecka et al.
JOURNAL OF NUCLEIC ACIDS (2010)
PARP-1 inhibition-induced activation of PI-3-kinase-Akt pathway promotes resistance to taxol
Arpad Szanto et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Akt Determines Replicative Senescence and Oxidative or Oncogenic Premature Senescence and Sensitizes Cells to Oxidative Apoptosis
Veronique Nogueira et al.
CANCER CELL (2008)
Integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer
Katherine Stemke-Hale et al.
CANCER RESEARCH (2008)
Evidence for the regulation of L-type Ca2+ channels in the heart by reactive oxygen species:: Mechanism for mediating pathology
Livia C. Hool
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2008)
Oxidative stress induces autophagic cell death independent of apoptosis in transformed and cancer cells
Y. Chen et al.
CELL DEATH AND DIFFERENTIATION (2008)
Interaction index and different methods for determining drug interaction in combination therapy
J. J. Lee et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2007)
Simultaneous inhibition of PDK1/AKT and Fms-like tyrosine kinase 3 signaling by a small-molecule KP372-1 induces mitochondrial dysfunction and apoptosis in acute myelogenous leukemia
ZH Zeng et al.
CANCER RESEARCH (2006)
The Akt inhibitor KP372-1 inhibits proliferation and induces apoptosis and anoikis in squamous cell carcinoma of the head and neck
M Mandal et al.
ORAL ONCOLOGY (2006)
Poly(ADP-ribosyl)ation by PARP-1: 'PAR-laying' NAD(+) into a nuclear signal
MY Kim et al.
GENES & DEVELOPMENT (2005)
DNA repair pathway stimulated by the forkhead transcription factor FOXO3a through the Gadd45 protein
H Tran et al.
SCIENCE (2002)
Functions of poly(ADP-ribose) polymerase (PARP) in DNA repair, genomic integrity and cell death
Z Herceg et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2001)
分享论文
